Therapeutic Advances and Challenges in the Management of HER2-Positive Gastroesophageal Cancers

Therapeutic Advances and Challenges in the Management of HER2-Positive Gastroesophageal Cancers

Gastroesophageal cancer is one of the most common cancers in the world, with a high rate of mortality. While there has been significant progress over the past decade, particularly with the addition of anti-HER2 therapies to platinum-based chemotherapy agents in the advanced setting, the prognosis re...

Full description

Bibliographic Details
Main Authors: Jeremy Chuang, Samuel Klempner, Kevin Waters, Katelyn Atkins, Joseph Chao, May Cho, Andrew Hendifar, Alexandra Gangi, Miguel Burch, Pareen Mehta, Jun Gong
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Diseases
Subjects:
gastroesophageal cancer
trastuzumab
HER2
next-generation sequencing
circulating tumor DNA
Online Access:https://www.mdpi.com/2079-9721/10/2/23

Internet

https://www.mdpi.com/2079-9721/10/2/23

Similar Items